Bruyaka, Olga; Zeitzmann, Hanko; Chalamon, Isabelle; … - In: Journal of Business Ethics 117 (2013) 1, pp. 45-65
In recent years, the biopharmaceutical industry has seen an increase in the development of so-called orphan drugs for … activities with a strategic orientation. The unique context of orphan drugs constitutes a research opportunity to test the …-based companies engaged in orphan drugs development perceive their involvement as a responsible business activity beyond the economic …